Skip to Content

Join Harrison and Walton lab

Current projects | Student research projects | Teaching activities

Interested in developing novel therapies to improve women’s lifetime health? Our research explores how growth factors in the TGF-β superfamily regulate female reproductive function, and what happens when the ovaries lose control at menopause. Using our extensive knowledge in TGF-β biology, our team also engineers targeted TGF-β therapies to treat reproductive and metabolic disorders.

Dr Walton and Professor Harrison have worked together for the past 12 years, and co-authored 37 research articles. As a team, they have supervised 8 honours, and 3 PhD students to completion. The Harrison-Walton lab is always looking for passionate, driven individuals to push the boundaries of research.

Whether you want to research, invest, donate or partner with us to accelerate our life-changing discoveries, we'd be delighted to hear from you. We have opportunities for PhD students, post docs and senior researchers to join our lab. Feel free to contact Professor Craig Harrison and Dr Kelly Walton with any queries.

Industry involvement

We are focused on translating our science and, as such, have three active patents focused on engineered TGF-β proteins. We perform contract research for Paranta Biosciences.

Dr Walton was awarded both First Prize and the People’s Choice award at the 2017 Monash Biomedicine Discovery Institute Industry Pitch Event. The exciting discoveries by the Harrison-Walton team attract engagement opportunities regularly with Australian Biotechnology Companies.

Selected funding groups

We gratefully acknowledge the funding given to our lab by the NHMRC, Cancer Council Victoria, Rebecca Cooper Foundation and Endocrine Society of Australia.

Teaching activities

Professor Harrison convenes PHY2032 – Endocrine Control Systems
Dr Walton lectures into PH3072 – Exercise Physiology and Metabolism